Press Releases Archive
06/05/2019 FDA Premarket Approval Granted for DT MedTech’s Hintermann Series H3™ Total Ankle Replacement System. 02/14/2018 DT MedTech Announces Successful Total Ankle Revision Procedures Using The New Hintermann Series H2™ Tibial Assembly Component and PE Inlay. 02/07/2018 DT MedTech Announces Successful Implantations of the New Hintermann Series H2™ Total Ankle Replacement Prosthesis. 11/08/2017 DT MedTech Announces 510(k) FDA Clearance … Read more

The Hintermann Series H3™ Total Ankle Replacement System is indicated for use as a non-cemented implant to replace a painful arthritic ankle joint due to primary osteoarthritis, post-traumatic osteoarthritis, or arthritis secondary to inflammatory disease (e.g., rheumatoid arthritis, hemochromatosis, etc.).